Character Biosciences is a precision medicine company developing targeted therapies for progressive polygenic diseases, starting with ophthalmology. By integrating genomics, deep clinical data, and AI-driven modeling, Character Bio identifies disease drivers to improve the success rate of drug development.
Market
Ophthalmology
Location
Jersey City,
New Jersey,
USA
Coinvestors
aMoon, Luma Group, Bausch + Lomb, Jefferson Life Sciences, Innovation Endeavors, Catalio Capital Management, S32, KdT Ventures